Point (s) of Article 3(1) and Article 19(6) of Regulation (EU) No 528/2012 should be amended to allow similar biocidal products to be part of a biocidal product family if they can be satisfactorily assessed based on identifiable maximum risks and minimum level of efficacy.
Recital 2, Regulation (EU) No 334/2014 of the European Parliament and of the Council of 11 March 20…
In forcesince 11 Mar 2014